LAURA AKERS: Open Payments
NPI 1972565638 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 9 companies in 2025. Trend: 2023 $877 · 2024 $712 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $45 |
| PFIZER INC. | 2 | $31 |
| Cleerly, Inc. | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $15 |
| ConvaTec Inc. | 1 | $14 |
Products named: LEQVIO, VYNDAQEL, Cleerly Ischemia, ONPATTRO, FUROSCIX, JARDIANCE, REPATHA, AQUACEL AG+ EXTRA.
Industry payments across FL — which companies pay providers there.
